These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 29247767)
21. Interaction of thioridazine with ocular melanin in vitro. Buszman E; Rózańska R Acta Pol Pharm; 2003; 60(4):257-61. PubMed ID: 14714852 [TBL] [Abstract][Full Text] [Related]
22. Understanding Molecular Drivers of Melanin Binding To Support Rational Design of Small Molecule Ophthalmic Drugs. Jakubiak P; Reutlinger M; Mattei P; Schuler F; Urtti A; Alvarez-Sánchez R J Med Chem; 2018 Nov; 61(22):10106-10115. PubMed ID: 30398862 [TBL] [Abstract][Full Text] [Related]
23. Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function. Simon JD; Peles D; Wakamatsu K; Ito S Pigment Cell Melanoma Res; 2009 Oct; 22(5):563-79. PubMed ID: 19627559 [TBL] [Abstract][Full Text] [Related]
24. Current understanding of the binding sites, capacity, affinity, and biological significance of metals in melanin. Hong L; Simon JD J Phys Chem B; 2007 Jul; 111(28):7938-47. PubMed ID: 17580858 [TBL] [Abstract][Full Text] [Related]
25. Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium. Pitkänen L; Ranta VP; Moilanen H; Urtti A Pharm Res; 2007 Nov; 24(11):2063-70. PubMed ID: 17546409 [TBL] [Abstract][Full Text] [Related]
26. Melanin and nicotine: A review of the literature. Yerger VB; Malone RE Nicotine Tob Res; 2006 Aug; 8(4):487-98. PubMed ID: 16920646 [TBL] [Abstract][Full Text] [Related]
27. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery. Tratta E; Pescina S; Padula C; Santi P; Nicoli S Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in ocular drug delivery. Achouri D; Alhanout K; Piccerelle P; Andrieu V Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114 [TBL] [Abstract][Full Text] [Related]
29. Overcoming ocular drug delivery barriers through the use of physical forces. Huang D; Chen YS; Rupenthal ID Adv Drug Deliv Rev; 2018 Feb; 126():96-112. PubMed ID: 28916492 [TBL] [Abstract][Full Text] [Related]
30. Redox Active Transition Metal ions Make Melanin Susceptible to Chemical Degradation Induced by Organic Peroxide. Zadlo A; Pilat A; Sarna M; Pawlak A; Sarna T Cell Biochem Biophys; 2017 Dec; 75(3-4):319-333. PubMed ID: 28401421 [TBL] [Abstract][Full Text] [Related]
31. Biological macromolecules for ophthalmic drug delivery to treat ocular diseases. Krishnaswami V; Kandasamy R; Alagarsamy S; Palanisamy R; Natesan S Int J Biol Macromol; 2018 Apr; 110():7-16. PubMed ID: 29378276 [TBL] [Abstract][Full Text] [Related]
32. Binding of antiglaucomatous drugs to synthetic melanin and their hypotensive effects on pigmented and nonpigmented rabbit eyes. Nagata A; Mishima HK; Kiuchi Y; Hirota A; Kurokawa T; Ishibashi S Jpn J Ophthalmol; 1993; 37(1):32-8. PubMed ID: 8100592 [TBL] [Abstract][Full Text] [Related]
33. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations. Shen J; Lu GW; Hughes P Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364 [TBL] [Abstract][Full Text] [Related]
34. Thallium-201: autoradiography in pigmented mice and melanin-binding in vitro. Tjälve H; Nilsson M; Larsson B Acta Pharmacol Toxicol (Copenh); 1982 Aug; 51(2):147-53. PubMed ID: 7113721 [TBL] [Abstract][Full Text] [Related]
35. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo. Ono C; Yamada M; Tanaka M J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591 [TBL] [Abstract][Full Text] [Related]
36. Binding of 14C-spermidine to melanin in vivo and in vitro. Tjälve H; Nilsson M; Larsson B Acta Physiol Scand; 1981 Jun; 112(2):209-14. PubMed ID: 7315415 [TBL] [Abstract][Full Text] [Related]
37. The red and the black. Simon JD; Peles DN Acc Chem Res; 2010 Nov; 43(11):1452-60. PubMed ID: 20734991 [TBL] [Abstract][Full Text] [Related]
38. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity. Debing I; Ijzerman AP; Vauquelin G Mol Pharmacol; 1988 Apr; 33(4):470-6. PubMed ID: 3357487 [TBL] [Abstract][Full Text] [Related]
39. The melanin binding of bisoprolol and its toxicological relevance. Steiner K; Bühring KU; Merck E Lens Eye Toxic Res; 1990; 7(3-4):319-33. PubMed ID: 1983104 [TBL] [Abstract][Full Text] [Related]
40. Age-related melanogenesis in the eye of mice, studied by microautoradiography of 3H-methimazole, a specific marker of melanin synthesis. Lindquist NG; Larsson BS; Stjernschantz J; Sjöquist B Exp Eye Res; 1998 Sep; 67(3):259-64. PubMed ID: 9778406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]